Blueprint to Close the Women%E2%80%99s Health Gap 2025

Notably, no single database comprehensively tracks how medications are used and distributed or medication quality. This has implications for the supply chain and patient access. And while knowing if recommended medications are tracked in global pharmaceutical data is important, the sparsity of relevant and accurate data needed for the analysis is reflective of broader challenges with data collection, standardization and collaboration between stakeholders for conditions that contribute to the women’s health gap. 2.1.2 Even if therapeutic products exist, knowing if they are accessible or used is impossible today The Forum and MHI developed metrics to reveal whether medications for the selected conditions are tracked globally. Analyses were conducted to understand if and how comprehensively the medicines for the selected conditions are tracked in global pharmaceutical data.74 Medication volumes are not comprehensively tracked for most selected conditions FIGURE 3 Note: 1. Model List Essential Medicines fr om the WHO: a list of medicines consider ed to be most ef fective and safe to meet the most important needs in a health system. 2. Global clinical practice guidelines for each condition, consider ed best practice. Sour ce: The Forum and MHI analysis, based on WHO Model List of Essential Medicines, CPGs of countries, IQVIA N/A N/A % of medications tracked in IQVIA 0–50% 50–75% >75%Medications are not fully tracked for >50% of conditions covered in the Model List of Essential Medicines Condition EML coverage score1 Endometriosis Menopause Premenstrual syndr ome Mater nal hypertensive disor der Migraine Post-partum haemorrhageCervical cancer Breast cancer Ischaemic heart diseaseCondition Endometriosis Menopause Premenstrual syndr ome Mater nal hypertensive disor der Migraine Post-partum haemorrhageCervical cancer Breast cancer Ischaemic heart diseaseMedications are adequately tracked for only ~44% of conditions; the remainder are poorly tracked CPG2 coverage score Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 15